Compare ALVO & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALVO | HLIO |
|---|---|---|
| Founded | 2013 | 1970 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2021 | 1996 |
| Metric | ALVO | HLIO |
|---|---|---|
| Price | $4.29 | $44.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $7.50 | ★ $76.67 |
| AVG Volume (30 Days) | ★ 904.9K | 501.1K |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 1.05% |
| EPS Growth | N/A | ★ 23.93 |
| EPS | N/A | ★ 1.79 |
| Revenue | N/A | ★ $200,727,000.00 |
| Revenue This Year | $10.60 | $7.18 |
| Revenue Next Year | $22.47 | $4.65 |
| P/E Ratio | ★ $18.20 | $25.54 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.94 | $45.60 |
| 52 Week High | $6.53 | $95.05 |
| Indicator | ALVO | HLIO |
|---|---|---|
| Relative Strength Index (RSI) | 39.19 | 19.73 |
| Support Level | $3.10 | N/A |
| Resistance Level | $4.59 | $70.81 |
| Average True Range (ATR) | 0.29 | 2.88 |
| MACD | -0.02 | -1.59 |
| Stochastic Oscillator | 16.48 | 2.56 |
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
Helios Technologies Inc is an industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic components and systems used to transmit power and control force, speed, and motion. There are two categories based on Hydraulic system architecture: MCT and FCT. The Electronics segment provides complete, fully-tailored display and control solutions for engines, engine-driven equipment, specialty vehicles, therapy baths, and traditional and swim spas. The company generates the majority of its revenue from the Hydraulics segment. Geographically, the company generates key revenue from the Americas region.